Rivus Pharmaceuticals is a biotechnology company focused on developing innovative therapies for the treatment of rare and infectious diseases.

Rivus Pharmaceuticals

Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus’ CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF). For more information please visit https://www.rivuspharma.com/

RxCapital

Longitude Capital

Medicxi

Bain Capital Life Sciences

BB Biotech Ventures

RA Capital Management

Rivus Pharmaceuticals 

We're developing a new class of investigational medicines that target energy consumption instead of energy intake, resulting in fat-specific weight-loss. Our CEO, Dr. Jayson Dallas, shares with PharmaVoice how our unique therapeutic approach stands out amidst a crowded landscape and how we are aiming to go beyond obesity to treat cardiometabolic diseases. Read more: https://bit.ly/3IUnp1T 

Metric
Company Name	Rivus Pharmaceuticals
Symbol
MSH ID	COM:RIVUSPHARMA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country
Stage
Employee Count	12
Website	rivuspharma.com
LinkedIn	rivus-pharmaceuticals
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	10.26
28-Day Growth Score	56.23
90-Day Growth Score	81.99
365-Day Growth Score	79.74

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:RIVUSPHARMA

Rivus Pharmaceuticals

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue